# Study of the Safety of USB005 in Healthy Volunteers

> **NCT03615196** · PHASE1 · COMPLETED · sponsor: **US Biotest, Inc.** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** USB005 (aclerastide) Ophthalmic Solution
- **DRUG:** USB005 Ophthalmic Solution Placebo

## Key facts

- **NCT ID:** NCT03615196
- **Lead sponsor:** US Biotest, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-25
- **Primary completion:** 2018-11-08
- **Final completion:** 2019-04-02
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03615196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03615196, "Study of the Safety of USB005 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03615196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*